Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

SELL
$1.15 - $3.34 $106,489 - $309,284
-92,600 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$2.96 - $7.76 $189,144 - $495,864
63,900 Added 222.65%
92,600 $285,000
Q3 2021

Oct 22, 2021

BUY
$9.18 - $14.15 $11,016 - $16,980
1,200 Added 4.36%
28,700 $331,000
Q2 2021

Jul 26, 2021

BUY
$8.07 - $12.52 $20,982 - $32,552
2,600 Added 10.44%
27,500 $344,000
Q4 2020

Jan 25, 2021

BUY
$5.98 - $12.47 $10,166 - $21,199
1,700 Added 7.33%
24,900 $207,000
Q3 2020

Dec 14, 2020

BUY
$4.65 - $8.73 $93,000 - $174,600
20,000 Added 625.0%
23,200 $142,000
Q2 2020

Jul 23, 2020

BUY
$4.66 - $8.7 $12,116 - $22,619
2,600 Added 433.33%
3,200 $26,000
Q1 2020

Apr 23, 2020

SELL
$5.05 - $15.01 $9,090 - $27,018
-1,800 Reduced 75.0%
600 $3,000
Q2 2019

Jul 25, 2019

BUY
$11.88 - $16.94 $28,512 - $40,656
2,400 New
2,400 $31,000

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $554M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.